XML 36 R34.htm IDEA: XBRL DOCUMENT

STOCK BASED COMPENSATION (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2013

Dec. 31, 2012

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

					Weighted
					Average			Weighted
		Number of			Exercise			Average			Aggregate
		shares under			Price Per			Fair			Intrinsic
		options			Share			Value			Value

Balance outstanding, March 31, 2012		7,975,125		$	1.38		$	0.70		$	5,613,510
Forfeited/Expired		(652,500	)		2.41			0.71			(460,975	)
Exercised		-			-			-			-
Granted		2,917,000			0.31			0.16			453,774
Balance outstanding, December 31, 2012		10,239,625			0.91			0.55			5,606,309
Forfeited/Expired		(1,566,375	)		2.18			1.20			(1,872,094	)
Exercised		-			-			-			-
Granted		3,215,000			0.42			0.25			808,500
Balance outstanding, September 30, 2013		11,888,250		$	0.61		$	0.38		$	4,542,715

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

		Nine Months			Nine Months
		Ended September			Ended December
		30, 2013			31, 2012
Dividend yield		0			0
Expected volatility		65 - 81%			65 - 70%
Risk free interest rate		0.19 - 0.81%			0.19 - 0.33%
Expected life (years)		4.65			3.17

Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

	OPTIONS OUTSTANDING
							REMAINING			NUMBER OF
	EXERCISE			NUMBER OF			CONTRACTUAL			OPTIONS
	PRICE			OPTIONS			LIFE (YEARS)			EXERCISABLE			INTRINSIC VALUE

$	0.92			1,698,250			0.65			1,698,250		$	1,200,208
	1.58			68,000			0.98			68,000			26,435
	0.86			1,300,000			1.95			1,300,000			752,207
	0.83			2,590,000			2.68			2,590,000			1,269,100
	0.60			100,000			2.95			100,000			36,072
	0.31			2,917,000			3.90			2,187,750			340,332
	0.46			1,950,000			4.81			487,500			118,414
	0.41			15,000			4.92			3,750			753
	0.35			1,250,000			9.55			312,500			84,500
$	0.61			11,888,250			3.68			8,747,750		$	3,828,021

	OPTIONS OUTSTANDING
							REMAINING			NUMBER OF
	EXERCISE			NUMBER OF			CONTRACTUAL			OPTIONS
	PRICE			OPTIONS			LIFE (YEARS)			EXERCISABLE			INTRINSIC VALUE

$	2.22			1,465,000			0.63			1,465,000		$	1,786,417
	1.78			95,000			0.74			95,000			81,172
	0.92			1,704,625			1.40			1,704,625			1,204,713
	1.58			68,000			1.73			68,000			26,435
	0.86			1,300,000			2.70			1,300,000			752,207
	0.83			2,590,000			3.43			2,590,000			1,269,100
	0.60			100,000			3.70			75,000			27,054
	0.31			2,917,000			4.65			729,250			113,444
$	0.91			10,239,625			2.80			8,026,875		$	5,260,542

Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]

					Weighted			Weighted
					Average Grant			Average
		Number of			Date Fair Value			Grant Date
		Options			Per Share			Fair Value

Nonvested, March 31, 2012		1,345,000		$	0.82		$	0.49
Granted		2,917,000			0.31			0.16
Vested		(2,049,250	)		0.64			0.37
Forfeited/Expired		-			-			-
Nonvested, December 31, 2012		2,212,750			0.31			0.16
Granted		3,215,000			0.42			0.25
Vested		(2,287,250	)		0.35			0.23
Forfeited/Expired		-			-			-
Nonvested, September 30, 2013		3,140,500		$	0.39		$	0.23

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

						Broker
						Warrant			Share			Warrant
			Broker			Exercise			Purchase			Exercise
	Expiration Date		Warrants			Price			Warrants			Price
	September 16, 2015		246,285		$	1.25			4,104,757		$	1.25
	May 31, 2017		255,721			0.44			-			-
	December 21, 2017		-			-			5,905,408			0.50

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References+ Details